Bank of Hawaii reduced its position in Express Scripts Holding Company (NASDAQ:ESRX) by 39.5% in the 2nd quarter, according to its most recent filing with the SEC. The firm owned 9,005 shares of the company’s stock after selling 5,873 shares during the period. Bank of Hawaii’s holdings in Express Scripts Holding were worth $575,000 at the end of the most recent reporting period.
A number of other hedge funds have also recently added to or reduced their stakes in the business. Park National Corp OH grew its stake in Express Scripts Holding by 0.3% in the 2nd quarter. Park National Corp OH now owns 3,575 shares of the company’s stock worth $228,000 after acquiring an additional 11 shares during the period. Parkside Financial Bank & Trust grew its stake in Express Scripts Holding by 0.3% in the 2nd quarter. Parkside Financial Bank & Trust now owns 8,634 shares of the company’s stock worth $551,000 after acquiring an additional 23 shares during the period. Carroll Financial Associates Inc. grew its stake in Express Scripts Holding by 1.0% in the 2nd quarter. Carroll Financial Associates Inc. now owns 3,186 shares of the company’s stock worth $203,000 after acquiring an additional 30 shares during the period. CAPROCK Group Inc. grew its stake in Express Scripts Holding by 0.9% in the 2nd quarter. CAPROCK Group Inc. now owns 3,675 shares of the company’s stock worth $235,000 after acquiring an additional 33 shares during the period. Finally, Sandy Spring Bank grew its stake in Express Scripts Holding by 0.6% in the 2nd quarter. Sandy Spring Bank now owns 6,464 shares of the company’s stock worth $413,000 after acquiring an additional 37 shares during the period. 88.69% of the stock is owned by hedge funds and other institutional investors.
Several analysts have commented on ESRX shares. Jefferies Group LLC set a $72.00 target price on shares of Express Scripts Holding and gave the stock a “buy” rating in a research note on Tuesday, August 29th. BidaskClub cut shares of Express Scripts Holding from a “hold” rating to a “sell” rating in a research note on Wednesday, July 12th. Royal Bank Of Canada started coverage on shares of Express Scripts Holding in a research note on Tuesday, September 19th. They issued a “sector perform” rating and a $68.00 target price for the company. UBS AG cut shares of Express Scripts Holding from a “market perform” rating to an “underperform” rating in a research note on Monday. Finally, Raymond James Financial, Inc. reaffirmed an “underperform” rating on shares of Express Scripts Holding in a research note on Monday. Six equities research analysts have rated the stock with a sell rating, eleven have given a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the stock. The company has an average rating of “Hold” and a consensus target price of $69.45.
Shares of Express Scripts Holding Company (NASDAQ ESRX) opened at 58.18 on Wednesday. The company’s 50-day moving average is $62.17 and its 200-day moving average is $62.57. Express Scripts Holding Company has a 12 month low of $57.80 and a 12 month high of $77.50. The stock has a market capitalization of $33.60 billion, a PE ratio of 10.10 and a beta of 0.88.
Express Scripts Holding (NASDAQ:ESRX) last announced its quarterly earnings results on Tuesday, July 25th. The company reported $1.73 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.71 by $0.02. Express Scripts Holding had a net margin of 3.50% and a return on equity of 25.58%. The company had revenue of $25.35 billion for the quarter, compared to analyst estimates of $25.52 billion. During the same quarter in the prior year, the business posted $1.57 EPS. Express Scripts Holding’s quarterly revenue was up .5% on a year-over-year basis. Equities research analysts expect that Express Scripts Holding Company will post $6.99 earnings per share for the current fiscal year.
In other news, Director Woodrow A. Myers, Jr. sold 3,900 shares of the stock in a transaction on Monday, September 11th. The shares were sold at an average price of $63.93, for a total transaction of $249,327.00. Following the transaction, the director now owns 11,500 shares in the company, valued at approximately $735,195. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, VP Everett Neville sold 1,163 shares of the firm’s stock in a transaction on Wednesday, August 23rd. The shares were sold at an average price of $61.48, for a total transaction of $71,501.24. Following the completion of the transaction, the vice president now owns 18,232 shares in the company, valued at $1,120,903.36. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 5,641 shares of company stock worth $357,317. 0.68% of the stock is currently owned by company insiders.
TRADEMARK VIOLATION WARNING: “Express Scripts Holding Company (ESRX) Holdings Reduced by Bank of Hawaii” was first posted by Community Financial News and is owned by of Community Financial News. If you are accessing this piece on another website, it was illegally stolen and reposted in violation of US and international copyright & trademark laws. The legal version of this piece can be accessed at https://www.com-unik.info/2017/10/11/express-scripts-holding-company-esrx-holdings-reduced-by-bank-of-hawaii.html.
Express Scripts Holding Profile
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).
Want to see what other hedge funds are holding ESRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts Holding Company (NASDAQ:ESRX).
What are top analysts saying about Express Scripts Holding Company? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Express Scripts Holding Company and related companies.